Respiri Ltd
ASX:RSH
Net Margin
Respiri Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
AU |
R
|
Respiri Ltd
ASX:RSH
|
96.8m AUD |
-686%
|
|
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
206.6B USD |
29%
|
||
US |
Abbott Laboratories
NYSE:ABT
|
193.4B USD |
14%
|
||
US |
Boston Scientific Corp
NYSE:BSX
|
142.8B USD |
11%
|
||
US |
Stryker Corp
NYSE:SYK
|
140.1B USD |
16%
|
||
IE |
Medtronic PLC
NYSE:MDT
|
109.4B USD |
13%
|
||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.5B USD |
9%
|
||
DE |
Siemens Healthineers AG
XETRA:SHL
|
57.7B EUR |
9%
|
||
US |
Edwards Lifesciences Corp
NYSE:EW
|
41.8B USD |
74%
|
||
US |
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
9%
|
||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
284.9B CNY |
33%
|
Respiri Ltd
Glance View
Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-07-14. The firm's segments include Australia and Israel. The Australia segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Israel. The firm has developed a wheezo, which is an eHealth Saas platform that uses a device and app to measure, record and assist asthma monitoring. Its device and app make up a cloud-based mobile health platform that records wheeze and other clinically relevant symptoms and signs of asthma.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Respiri Ltd's most recent financial statements, the company has Net Margin of -686.5%.